MATERIAL AND METHODS
). Thirteen patients demonstrated recurrences. Of these, 7 patients died ( Table 2 ).
In a comparative study, differences in the mean age at diagnosis and duration between the first and second cancer diagnosis were found not to be statistically significant between the two groups. (Fig.2) .
We subsequently stratified the patients according to stage change between the two cancer events.
The stage of the second breast malignancy was similar or improved in 28 patients (63.6%), and (Table 4) .
Group 1 (n = 28) Group 2 (n = 12) P-value

DISCUSSION
The annual incidence rate of metachronous CBC has been reported to be approximately 0.3% to 0.6%. 9 Recent studies have been published which suggest that the incidence rate of metachronous Risk of developing contralateral breast cancer is high in young age and this is demonstrated in recent report using National Cancer Institute's Surveillance, Epidemiology, and End Result database. 10 In our study, age of first breast cancer was younger in metachronous bilateral breast cancer patients than unilateral breast cancer patients.
Estrogen receptor negative-breast cancer is another risk for developing CBC, because tamoxifen and aromatase inhibitor has contributed to decrease the incidence rates of CBC in estrogen pos- 14 Mutation of BRCA gene is also a contributing factor for CBC, so careful surveillance on contralateral breast is mandatory in breast cancer patients with positive BRCA mutation. 15, 16 Bilateral breast cancer is known to be associated with a higher risk of mortality than unilateral breast cancer, with poorer outcomes recorded in a subgroup of patients that exhibited younger-onset and shorter durations between the first and second cancer diagnosis. 11, [17] [18] [19] Several studies have reported mean durations between the occurrence of the primary breast cancer and CBC as being > 5 years, which means patients need to pay careful attention to their contralateral breast for a significant amount of time after receiving treatment for the primary breast cancer. 17, 20 In these patients, an annual MMG and physical examination are recommended as routine practice. This study has several limitations, including its retrospective design. It is also a single center study with a relatively small cohort, owing to the fact that the incidence rates of CBC are exceedingly low and the durations between the two cancer events are long. Nationwide studies can derive more precise and high-level prognostic value on regular MMG follow-up.
In conclusion, CBC represents the most common second primary cancer among breast cancer survivors. Routine screening of the contralateral breast could enhance the early detection of CBC, possibility of breast conserving surgery, and enhanced breast cancer-specific survival outcomes.
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